Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Wellnex Life Limited (WNX.AX)
Port Melbourne, VIC, AU
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.23% | -10.45% | -20.00% | -42.86% | -67.57% | -36.17% | -78.57% | -97.01% | -99.68% | -99.13% | -99.13% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-08 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Food Distribution: +7.7%+39.5% ★ Q4'25: +128.5% (vs Q4'23)
-
EPS growth Food Distribution: +4.1%+34.6% ★ Q4'25: +95.6% (vs Q4'23)
-
FCF margin FCF growth · Food Distribution: +15.4%-39.1% Q4'25: -24.3% (vs Q4'23)
-
EBIT margin Food Distribution: +3.6%-33.9% Q4'25: -7.4% (vs Q4'23)
-
ROIC Food Distribution: +6.5%-49.4% Q4'25: -20.0% (vs Q4'23)
-
Share dilution Food Distribution: +0.0%+72.1% Q4'25: +311.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Food Distribution: 0.80×-0.82× Q4'25: -8.31× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
Jun 2027 1 Rev. Ana. 1 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
Jun 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
27.89M
est: 28.60M (-2.5%)
|
16.93M
est: 36.60M (-53.7%)
|
23.63M
est: 24.70M (-4.4%)
|
34.60M
34.60M – 34.60M
+40.1% YoY
|
48.60M
48.60M – 48.60M
+40.5% YoY
|
63.70M
63.70M – 63.70M
+31.1% YoY
|
80.60M
80.60M – 80.60M
+26.5% YoY
|
| EBITDA |
-6.82M
est: -14.24M (+52.1%)
|
-10.57M
est: -18.23M (+42.0%)
|
-6.62M
est: -12.30M (+46.2%)
|
-17.23M
-17.23M – -17.23M
-40.1% YoY
|
-24.20M
-24.20M – -24.20M
-40.5% YoY
|
-31.73M
-31.73M – -31.73M
-31.1% YoY
|
-40.14M
-40.14M – -40.14M
-26.5% YoY
|
| EBIT |
-7.10M
est: -14.94M (+52.5%)
|
-11.34M
est: -19.12M (+40.7%)
|
-8.00M
est: -12.90M (+38.0%)
|
-18.08M
-18.08M – -18.08M
-40.1% YoY
|
-25.39M
-25.39M – -25.39M
-40.5% YoY
|
-33.28M
-33.28M – -33.28M
-31.1% YoY
|
-42.11M
-42.11M – -42.11M
-26.5% YoY
|
| Net Income |
-13.85M
est: 2.01M (-788.4%)
|
-13.74M
est: 6.03M (-327.7%)
|
-15.60M
est: -2.63M (-492.5%)
|
292.6K
292.6K – 292.6K
+111.1% YoY
|
1.46M
1.46M – 1.46M
+400.0% YoY
|
2.34M
2.34M – 2.34M
+60.0% YoY
|
3.51M
3.51M – 3.51M
+50.0% YoY
|
| SGA |
11.58M
est: 52.64M (-78.0%)
|
10.75M
est: 67.37M (-84.0%)
|
13.50M
est: 45.46M (-70.3%)
|
63.69M
63.69M – 63.69M
+40.1% YoY
|
89.46M
89.46M – 89.46M
+40.5% YoY
|
117.25M
117.25M – 117.25M
+31.1% YoY
|
148.36M
148.36M – 148.36M
+26.5% YoY
|
| EPS |
-0.82
est: 0.07 (-1,292.9%)
|
-0.81
est: 0.21 (-492.8%)
|
-0.53
est: -0.09 (-488.9%)
|
0.01
0.01 – 0.01
+111.1% YoY
|
0.05
0.05 – 0.05
+400.0% YoY
|
0.08
0.08 – 0.08
+60.0% YoY
|
0.12
0.12 – 0.12
+50.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Zlatko Bozinovski | Chief Strategy Officer | 392.3K | male |
| Yuan Zhang | Chief Financial Officer | 221.9K | female |
| Zheng Li | Company Secretary | 150.5K | male |
| Eric Jiang | Executive Chair | 46.7K | male |
| Nick Krogh | Sales & Marketing Manager | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for WNX.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
